Streetbeat News

Regulatory

THCX

The cannabis industry is poised for growth as legalization efforts expand in the US. Ancillary cannabis companies, which provide essential products for cultivation, are expected to benefit significantly by 2025 due to advancing legislation and technology.

Portfolio Pulse from

January 12, 2025 | 3:15 pm

BAC

Bank of America is expected to showcase the initial impact of AI-driven cost cuts in its Q4 earnings, potentially adding $17.37 billion annually by 2027. Anticipated regulatory easing post-2024 US Presidential election has also driven its shares to outpace the market.

Portfolio Pulse from

January 12, 2025 | 7:00 am

AAPL

Apple's board of directors has advised shareholders to vote against a proposal to eliminate the company's Diversity, Equity, and Inclusion (DEI) programs. This recommendation was made in a proxy filing.

Portfolio Pulse from

January 12, 2025 | 2:00 am

NNOMF

Nano One Materials Corp is advancing its LFP battery solutions in response to proposed Chinese export restrictions. The company's One-Pot process could enhance North American supply chains by providing a localized, waste-free alternative.

Portfolio Pulse from

January 11, 2025 | 7:00 pm

PACS

Hagens Berman is investigating allegations of Medicare fraud against PACS Group. Investors who have incurred losses are encouraged to contact the firm before the January 13, 2025 deadline.

Portfolio Pulse from

January 11, 2025 | 6:30 pm

THCX

The cannabis sector in 2025 has faced challenges, notably due to Florida voters rejecting Amendment 3, which aimed to legalize recreational cannabis. This has caused a market pullback, but long-term growth potential remains. The article highlights top U.S. cannabis companies and trading strategies.

Portfolio Pulse from

January 11, 2025 | 4:15 pm

BTI

British American Tobacco (BTI) is recommended for purchase due to its adaptation to changing consumer preferences, despite regulatory challenges and declining cigarette usage. The company is focusing on emerging products like oral nicotine pouches and electronic devices.

Portfolio Pulse from

January 11, 2025 | 4:00 pm

GVXXF

GoviEx Uranium Inc provided an update on its Muntanga project in Zambia, indicating that the feasibility study is nearing completion. This progress will enable the company to advance financing discussions and finalize ESIA approvals.

Portfolio Pulse from

January 11, 2025 | 3:15 pm

MIRM

NDAQ

Mirum Pharmaceuticals announced inducement grants under Nasdaq Listing Rule 5635(c)(4).

Portfolio Pulse from

January 10, 2025 | 11:45 pm